BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15972409)

  • 1. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging.
    Tadamura E; Yamamuro M; Kubo S; Kanao S; Saga T; Harada M; Ohba M; Hosokawa R; Kimura T; Kita T; Togashi K
    AJR Am J Roentgenol; 2005 Jul; 185(1):110-5. PubMed ID: 15972409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Previous studies on delayed enhanced MRI for the detection of cardiac sarcoidosis.
    Smedema JP; Tadamura E
    AJR Am J Roentgenol; 2006 Feb; 186(2):578; author reply 578-9. PubMed ID: 16423972
    [No Abstract]   [Full Text] [Related]  

  • 3. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis.
    Matoh F; Satoh H; Shiraki K; Odagiri K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Cardiol; 2008 Jun; 51(3):179-88. PubMed ID: 18522793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis.
    Tawarahara K; Kurata C; Okayama K; Kobayashi A; Yamazaki N
    Am Heart J; 1992 Nov; 124(5):1383-4. PubMed ID: 1442515
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac sarcoidosis demonstrated by Tl-201 and Ga-67 SPECT imaging.
    Taki J; Nakajima K; Bunko H; Ohguchi M; Tonami N; Hisada K
    Clin Nucl Med; 1990 Sep; 15(9):636-9. PubMed ID: 2208885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radionuclide assessment of cardiac involvement in patients with sarcoidosis].
    Hiroe M; Nagata M; Sekiguchi M; Ohta Y; Kusakabe K; Shigeta A; Horie T; Fujita N; Hasumi M; Toyosaki T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):56-64. PubMed ID: 2162435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis.
    Okayama K; Kurata C; Tawarahara K; Wakabayashi Y; Chida K; Sato A
    Chest; 1995 Feb; 107(2):330-4. PubMed ID: 7842756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The difficult diagnosis of isolated cardiac sarcoidosis: usefulness of an integrated MRI and PET approach.
    Galati G; Leone O; Rapezzi C
    Heart; 2014 Jan; 100(1):89-90. PubMed ID: 23838000
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnetic resonance imaging and nuclear imaging in sarcoidosis.
    Mañá J
    Curr Opin Pulm Med; 2002 Sep; 8(5):457-63. PubMed ID: 12172453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation.
    Kiuchi S; Teraoka K; Koizumi K; Takazawa K; Yamashina A
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):237-41. PubMed ID: 16868855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide imaging in myocardial sarcoidosis. Demonstration of myocardial uptake of technetium pyrophosphate99m and gallium.
    Forman MB; Sandler MP; Sacks GA; Kronenberg MW; Powers TA
    Chest; 1983 Mar; 83(3):578-80. PubMed ID: 6297857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.
    Yang Y; Safka K; Graham JJ; Roifman I; Zia MI; Wright GA; Balter M; Dick AJ; Connelly KA
    J Magn Reson Imaging; 2014 Mar; 39(3):609-16. PubMed ID: 23720077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of thallium 201 scanning in the management of myocardial sarcoidosis.
    Sharma OP; Siegel M; Haywood LJ
    Arch Monaldi; 1981; 36(3):79-86. PubMed ID: 7348542
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
    Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
    J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac sarcoidosis detected by delayed-hyperenhancement magnetic resonance imaging.
    Nemeth MA; Muthupillai R; Wilson JM; Awasthi M; Flamm SD
    Tex Heart Inst J; 2004; 31(1):99-102. PubMed ID: 15061637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of multimodality imaging including Thallium-201 myocardial perfusion imaging in the diagnosis and monitoring of treatment response in cardiac sarcoidosis.
    Surasi DS; Manapragada PP; Lloyd SG; Bhambhvani P
    J Nucl Cardiol; 2014 Aug; 21(4):849-52. PubMed ID: 24493414
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic Value of PET in Cardiac Sarcoidosis.
    Smedema JP; van Kroonenburgh MJ; Snoep G; Bekkers SC; Gorgels AP
    J Nucl Med; 2004 Nov; 45(11):1975. PubMed ID: 15534072
    [No Abstract]   [Full Text] [Related]  

  • 18. Scintigraphic demonstration of myocardial sarcoidosis: the added value of single-photon emission computed tomography.
    Barneveld PC; van Leeuwen C; van Isselt JW
    J Nucl Cardiol; 1997; 4(3):256-7. PubMed ID: 9199265
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in radionuclide imaging of cardiac sarcoidosis.
    Kouranos V; Wells AU; Sharma R; Underwood SR; Wechalekar K
    Br Med Bull; 2015 Sep; 115(1):151-63. PubMed ID: 26311504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case with cardiac sarcoidosis. Significance of the effect of steroids on the reversion of advanced atrioventricular block and myocardial scintigraphic abnormalities.
    Fujita N; Hiroe M; Suzuki Y; Sato H; Inoue Y; Sekiguchi M; Hosoda S
    Heart Vessels Suppl; 1990; 5():16-8. PubMed ID: 1965540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.